Upregulation of Neuroinflammatory Protein Biomarkers in Acute Rhegmatogenous Retinal Detachments.
Minali PrasadJia XuJoshua S AgranatWeiming XiaSarah DaleySteven NessXuejing ChenNicole H SiegelThor D SteinJaeyoon ChungManju L SubramanianPublished in: Life (Basel, Switzerland) (2022)
The purpose of this study is to characterize the inflammatory cytokine profile in rhegmatogenous retinal detachments (RRDs) compared to surgical controls. Vitreous humor was collected from patients undergoing vitrectomy for RRD and noninflammatory vitreoretinal diseases. A quantitative immunoassay was used to measure the levels of 36 cytokine markers. Linear regression analysis with the duration of detachment as the predictor and log-transformed cytokine levels as the outcome was conducted for normally distributed cytokines as determined by the Shapiro-Wilk test. The analysis was adjusted for age, sex, and race. The Kruskal-Wallis test was used for cytokines not normally distributed. Twenty-seven RRD cases and thirteen control cases were studied. Between all RRDs and controls, fibroblast growth factor 2 (FGF2) ( p = 0.0029), inducible protein-10(IP-10) ( p = 0.0021), monocyte chemoattractant protein-1 (MCP-1) ( p = 0.0040), interleukin (IL)-16 ( p = 0.018), IL-8 ( p = 0.0148), IL-6 ( p = 0.0071), eotaxin ( p = 0.0323), macrophage inflammatory protein (MIP)-1 alpha ( p = 0.0149), MIP-1 beta ( p = 0.0032), and the thymus and activation regulated cytokine (TARC) ( p = 0.0121) were elevated in RRD cases. Between acute RRDs (n = 16) and controls, FGF2 ( p = 0.0001), IP10 ( p = 0.0027), MCP-1 ( p = 0.0015), MIP-1β ( p = 0.0004), IL-8 ( p = 0.0146), and IL-6 ( p = 0.0031) were elevated. Determining alterations in inflammatory cytokine profiles may aid in understanding their impact on RRD development, clinical course, and complications before and after surgical repair.
Keyphrases